Answers are grounded in this paper and cite their sources.
A study using daily topical applications of dinitrochlorobenzene on recalcitrant verrucae vulgares demonstrated this to be of practical value. Complete resolution of lesions occurred in 66% of 35 patients, with a complication rate of 24%. The results of other studies are reviewed and recommendations for use of this medication are given. DNCB therapy should, however, be reserved for use on recalcitrant lesions because of the complications associated with its usage.
No takes yet. Share an insight, caveat, or question.
BUCKNER et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: